Persistence of an Infectious Form of SARS-CoV-2 After Protease Inhibitor Treatment of Permissive Cells In Vitro

• by Manoj S Nair, Maria I Luck, Yaoxing Huang, Yosef Sabo, David D Ho

• August 12, 2024

Assessing PEPFAR’s Health Spillover Effects Beyond HIV: An Update

• by Jennifer Kates, William Crown, Collins Gaba, Monica Jordan, Allyala Nandakumar

• May 20, 2026

Long COVID Persistence and Surveillance Gaps Across 58 US Hospitals

• by Jiazi Tian, Alaleh Azhir, Matthew Decaro, Ngan Chau, Jonas Hügel, Michele Morris, Jingya Cheng, Pedram Fard, Ingrid V. Bassett, Douglas S. Bell, Elmer V. Bernstam, Shyam Visweswaran, Jeffrey G. Klann, Shawn N. Murphy, Hossein Estiri

• May 27, 2026

Early ICU Rehab Backed, With Caveats

Invited narrative review supports early, interprofessional rehabilitation across the ICU recovery continuum while emphasizing heterogeneous evidence and inconsistent implementation worldwide.

• by Andrea Surnit

• May 11, 2026

• 8 min